AR104539A1 - Compuestos cíclicos - Google Patents
Compuestos cíclicosInfo
- Publication number
- AR104539A1 AR104539A1 ARP160101293A ARP160101293A AR104539A1 AR 104539 A1 AR104539 A1 AR 104539A1 AR P160101293 A ARP160101293 A AR P160101293A AR P160101293 A ARP160101293 A AR P160101293A AR 104539 A1 AR104539 A1 AR 104539A1
- Authority
- AR
- Argentina
- Prior art keywords
- optionally substituted
- group
- ring
- substituents selected
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/12—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Reivindicación 1: Un compuesto representado por la fórmula (1) o una sal del mismo (caracterizado porque, el anillo A es ciclopenteno o ciclohexeno; el anillo B es un anillo de benceno sustituido en forma opcional por 1 a 3 sustituyentes seleccionados entre un átomo de halógeno y un grupo alquilo C₁₋₆; en cuanto a R¹ y R², (i) R¹ y R² son ambos átomos de hidrógeno, o (ii) uno de R¹ y R² es un átomo de hidrógeno, y el otro es un grupo hidroxi, o R¹ y R² se pueden unir entre sí para formar un heterociclo monocíclico no aromático de 3 a 8 miembros, que está sustituido en forma opcional por 1 a 3 grupos alquilo C₁₋₆ sustituidos en forma opcional por 1 a 3 sustituyentes seleccionados de un grupo hidroxi y un grupo alcoxi C₁₋₆; W es CH₂ u O; y R³ es un grupo alcoxi C₁₋₆ sustituido en forma opcional por 1 a 3 grupos cicloalquilo C₃₋₁₀ sustituidos en forma opcional por 1 a 3 grupos alquilo C₁₋₆).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015095817 | 2015-05-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR104539A1 true AR104539A1 (es) | 2017-07-26 |
Family
ID=56132991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP160101293A AR104539A1 (es) | 2015-05-08 | 2016-05-06 | Compuestos cíclicos |
Country Status (11)
Country | Link |
---|---|
US (3) | US9611244B2 (es) |
EP (1) | EP3294706B1 (es) |
JP (1) | JP6718884B2 (es) |
CN (1) | CN107835800B (es) |
AR (1) | AR104539A1 (es) |
CA (1) | CA2985325C (es) |
EA (1) | EA033083B1 (es) |
ES (1) | ES2772703T3 (es) |
TW (1) | TW201704206A (es) |
UY (1) | UY36675A (es) |
WO (1) | WO2016182036A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR104539A1 (es) * | 2015-05-08 | 2017-07-26 | Takeda Pharmaceuticals Co | Compuestos cíclicos |
RU2742337C2 (ru) | 2016-09-09 | 2021-02-04 | Такеда Фармасьютикал Компани Лимитед | Циклическое соединение |
FR3095755A1 (fr) * | 2019-05-10 | 2020-11-13 | Balmes Transplantation | Nouveaux médicaments cytoprotecteurs |
CN114425054A (zh) * | 2022-01-20 | 2022-05-03 | 中国人民解放军军事科学院军事医学研究院 | 一种蛋白酶体抑制剂Bortezomib在抗辐射损伤中的用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1063228E (pt) | 1998-03-09 | 2005-05-31 | Takeda Pharmaceutical | Derivados de cicloalcenos processo para a sua preparacao e utilizacao |
EP1209149B9 (en) | 1999-08-06 | 2011-08-31 | Takeda Pharmaceutical Company Limited | Substituted aromatic-ring compounds, process for producing the same, and use |
JP2004002370A (ja) * | 2002-04-08 | 2004-01-08 | Takeda Chem Ind Ltd | 重症セプシス予防治療剤 |
WO2003084527A1 (fr) | 2002-04-08 | 2003-10-16 | Takeda Chemical Industries, Ltd. | Agent therapeutique pour la prevention d'etat septique grave |
CA2622694C (en) * | 2005-09-14 | 2011-02-08 | Daiichi Sankyo Company, Limited | Substituted cycloalkene derivative |
JP2008260760A (ja) * | 2007-03-12 | 2008-10-30 | Daiichi Sankyo Co Ltd | 置換シクロアルケン誘導体を含有する医薬組成物 |
US20100137247A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Anti-inflammatory compositions and methods |
CN104744321A (zh) | 2010-01-27 | 2015-07-01 | 武田药品工业株式会社 | 用于抑制由抗癌剂诱导的外周神经障碍的化合物 |
AR104539A1 (es) * | 2015-05-08 | 2017-07-26 | Takeda Pharmaceuticals Co | Compuestos cíclicos |
-
2016
- 2016-05-06 AR ARP160101293A patent/AR104539A1/es unknown
- 2016-05-06 EP EP16729646.6A patent/EP3294706B1/en active Active
- 2016-05-06 JP JP2017555812A patent/JP6718884B2/ja active Active
- 2016-05-06 TW TW105114092A patent/TW201704206A/zh unknown
- 2016-05-06 CA CA2985325A patent/CA2985325C/en active Active
- 2016-05-06 UY UY0001036675A patent/UY36675A/es not_active Application Discontinuation
- 2016-05-06 WO PCT/JP2016/064204 patent/WO2016182036A1/en active Application Filing
- 2016-05-06 EA EA201792469A patent/EA033083B1/ru not_active IP Right Cessation
- 2016-05-06 ES ES16729646T patent/ES2772703T3/es active Active
- 2016-05-06 CN CN201680040064.1A patent/CN107835800B/zh active Active
- 2016-05-06 US US15/148,210 patent/US9611244B2/en active Active
- 2016-06-07 US US15/175,292 patent/US9533966B2/en active Active
- 2016-11-21 US US15/356,906 patent/US9828357B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US9611244B2 (en) | 2017-04-04 |
BR112017023818A2 (pt) | 2018-07-31 |
CA2985325A1 (en) | 2016-11-17 |
CN107835800B (zh) | 2019-11-26 |
ES2772703T3 (es) | 2020-07-08 |
CN107835800A (zh) | 2018-03-23 |
CA2985325C (en) | 2023-09-26 |
EA201792469A1 (ru) | 2018-06-29 |
JP2018516875A (ja) | 2018-06-28 |
US9533966B2 (en) | 2017-01-03 |
US20170066737A1 (en) | 2017-03-09 |
US9828357B2 (en) | 2017-11-28 |
EA033083B1 (ru) | 2019-08-30 |
WO2016182036A1 (en) | 2016-11-17 |
EP3294706A1 (en) | 2018-03-21 |
TW201704206A (zh) | 2017-02-01 |
US20160326102A1 (en) | 2016-11-10 |
UY36675A (es) | 2016-12-30 |
JP6718884B2 (ja) | 2020-07-08 |
US20160326133A1 (en) | 2016-11-10 |
EP3294706B1 (en) | 2019-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2017000149A (es) | Compuestos de triazolopirimidina y usos de los mismos | |
AR095823A1 (es) | Compuesto de ciclopropanamina y uso del mismo | |
CU24411B1 (es) | Compuesto derivado de benzamida sustituida con 1,3-tiazol-2-ilo útil para el tratamiento de trastornos neurogénicos | |
AR100645A1 (es) | Derivados de pirazolo-pirimidina | |
AR090760A1 (es) | Compuestos de benzotiazol y su uso contra el virus de hiv | |
AR094812A1 (es) | Derivado de piridina monocíclico como inhibidor del fgfr | |
CU20160052A7 (es) | Amino-heteroaril-benzamidas como inhibidores de cinasa | |
AR101558A1 (es) | Difluoropirrolidinas como moduladores del receptor de orexina | |
CO2017001178A2 (es) | Derivado de piridona que tiene un grupo tetrahidropiranil metilo | |
AR101815A1 (es) | Compuestos y composiciones como inhibidores de quinasa | |
AR097866A1 (es) | Derivados de 4-azaindol | |
AR105668A1 (es) | 2-amino-3-fluoro-3-(fluorometil)-6-metil-6-fenil-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 | |
AR098522A1 (es) | Compuesto de triazolo-piridina | |
AR104539A1 (es) | Compuestos cíclicos | |
AR104342A1 (es) | Compuesto heterocíclico | |
AR105549A1 (es) | Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos | |
CU20170007A7 (es) | Compuestos de imidazopiridazina | |
AR097932A1 (es) | Antagonista del receptor de somatostatina del subtipo 5 (sstr5) | |
AR097253A1 (es) | Derivado de pirazolilpirazol sustituido y el uso del mismo como herbicida | |
AR102544A1 (es) | Compuestos derivados de dihidrohidantoína como herbicidas | |
CU20160148A7 (es) | Compuestos de azol sustituidos con amida como inhibidores de tnks1 y/o tnks2 | |
AR128158A2 (es) | Compuesto heterocíclico | |
AR102957A1 (es) | Combinaciones de compuestos activos | |
AR098965A1 (es) | Derivados de sulfonamidas tricíclicas | |
CU24438B1 (es) | Compuestos derivados de 1,6 naftiridina-diona activos como supresores de mutación sin sentido |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |